Results 211 to 220 of about 25,610 (245)
Some of the next articles are maybe not open access.
Biological chemistry Hoppe-Seyler, 1995
The urokinase-type plasminogen activator (uPA) is secreted as a single-chain inactive zymogen (pro-uPA). Upon its secretion, pro-uPA binds to its glycosylphosphatidylinositol-anchored specific cell receptor (uPAR). The activation of pro-uPA to the active two-chain uPA is accelerated with uPAR-bound pro-uPA and is achieved by plasmin and proteases of ...
CONESE, MASSIMO, F. Blasi
openaire +1 more source
The urokinase-type plasminogen activator (uPA) is secreted as a single-chain inactive zymogen (pro-uPA). Upon its secretion, pro-uPA binds to its glycosylphosphatidylinositol-anchored specific cell receptor (uPAR). The activation of pro-uPA to the active two-chain uPA is accelerated with uPAR-bound pro-uPA and is achieved by plasmin and proteases of ...
CONESE, MASSIMO, F. Blasi
openaire +1 more source
Urokinase and its Receptor: Markers of Malignancy?
1994For many years it has been known that abnormal coagulation and fibrinolytic activity existed in the environs of malignant tumours. Whether these activities affected the invasiveness and metastatic activity of tumours has been in question for some time.
P J, Gaffney, D A, Cooke, K G, Burnand
openaire +2 more sources
Function of Receptor-Bound Urokinase
Seminars in Thrombosis and Hemostasis, 1991J C, Kirchheimer, B R, Binder
openaire +2 more sources
Critical care management of chimeric antigen receptor T‐cell therapy recipients
Ca-A Cancer Journal for Clinicians, 2022Alexander Shimabukuro-Vornhagen +2 more
exaly
Current treatment and recent progress in gastric cancer
Ca-A Cancer Journal for Clinicians, 2021Smita S Joshi, Brian D Badgwell
exaly